Geriatric care will become increasingly important over coming decades as life expectancy increases. F. Nourhashemi describes how the standardized geriatric evaluation is changing to incorporate new understanding of the evolution and impact of frailty and trajectories of disability among elderly people.
Summary
Introduction : Definitions & Objectives of the colloquium: Selective choices among relevant areas with established therapeutic progress. Dominique BELLET et Jean-Paul TILLEMENT
New diagnostic and Therapeutic Technologies
Integration of individual genetic and kinetic characteristics for the pharmacological optimization of drug use. Pierre MARQUET
Toward precision medicine for age-related diseases: standardized geriatric assessment. Fati NOURHASHEMI
Genomic and precision medicine: setting problems and perspectives. Francis GALIBERT
Managing drug interactions: a clinical decision support system. Jacques TURGEON
Therapeutic targeting of Interleukin 17: An example of translational medicine. Pierre MIOSSEC
Realities and perspetives of precision medicine
Type 2 diabetes and hypercholesterolemia. André SCHEEN
Should we sequence each patient's tumour? Christophe LE TOURNEAU
Kidney transplantation: an emblematic example of precision medicine to solve an increasingly complex situation. Thierry HAUET
Gene, cellular and stem-cell therapies: perspectives and limits. Salima HACEIN-BEY
Precision Medicine: which applications, cost and targeted populations? Jean-Pierre MICHEL
Organizers
Authors
Organizers
Authors
Category
The patient
Publication type
Proceedings
Year
2017
Download the publication Others publications
Oncology
Malignant, locally aggressive connective tissue tumours
The patient
Gene Therapy: clinical achievements and future prospects
Immunology
Mini Colloquium ''Immunoregulation and cancer'': Interview of Pr Caroline ROBERT
The patient
Realities and future prospects of precision medicine. Type 2 diabetes and hypercholesterolaemia